Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Search
Medicines Law & Policy
Research and resources on intellectual property and health
Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Tag: WHO
WHO’s Essential Medicines Committee takes aim at rising prices, adds new...
Kaitlin Mara
-
October 6, 2021
Independent Panel for Pandemic Preparedness and Response: Uneven access to vaccination...
Kaitlin Mara
-
May 12, 2021
Ensuring that intellectual property rights aren’t a barrier to scaling-up: the...
Medicines Law & Policy
-
April 13, 2021
The elephant in the room at the WHO Executive Board
Ellen 't Hoen
-
January 22, 2021
Wrapping up 2020 with some noteworthy medicines, law and policy events
Medicines Law & Policy
-
December 29, 2020
Human Rights Watch: All governments should endorse the WHO C-TAP Solidarity...
Kaitlin Mara
-
October 30, 2020
WTO Members discuss proposal to suspend certain intellectual property protection during...
Ellen 't Hoen
-
October 14, 2020
Medicines Law & Policy welcomes WHO’s Solidarity Call to Action to...
Medicines Law & Policy
-
May 29, 2020
Invitation: 14 May 2020 – The WHO Covid-19 Technology Pool: The...
Kaitlin Mara
-
May 12, 2020
The € 7.4 billion for Covid-19 product and vaccine development needs...
Ellen 't Hoen
-
May 5, 2020
1
2
3
Page 1 of 3
This work is licensed under Creative Commons.